Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

6-Month, Phase 3, Randomized, Double-blind, Parallel-group, Controlled, Multi-center Study Evaluate Gastric Ulcer Incidence Following Administration of PN400 or Naproxen in Subjects Who Are at Risk for Developing NSAID-associated Ulcers

NCT01129011 is registered in ClinicalTrials.gov with POZEN as lead sponsor.

NCT NCT01129011
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01129011 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
6-Month, Phase 3, Randomized, Double-blind, Parallel-group, Controlled, Multi-center Study Evaluate Gastric Ulcer Incidence Following Administration of PN400 or Naproxen in Subjects Who Are at Risk for Developing NSAID-associated Ulcers
Lead sponsor
POZEN
Phase
Phase 3
Overall status
Completed
Start date
September 30, 2007
Completion date
October 31, 2008
Enrollment
420 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

gastric ulcer